This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aranow, C Articles by Ginzler, E M Search for Related Content PubMed PubMed Citation Articles by Aranow, C Articles by Ginzler, E M Social Bookmarking                   What's this?

Epidemiology of cardiovascular disease in systemic lupus erythematosus

SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY, USA

E M Ginzler

SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY 11203, USA Lupus

Awareness of the impact of cardiovascular disease on the late morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary to accelerated atherosclerosis have been documented in lupus cohorts across the globe. We review the history and epidemiology of cardiovascular disease in patients with SLE.

Key Words: systemic lupus erythematosus • coronary artery disease • atherosclerosis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Mathieu, H. Joly, G. Baron, A. Tournadre, J.-J. Dubost, J.-M. Ristori, J.-R. Lusson, and M. Soubrier Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease Rheumatology, August 1, 2008; 47(8): 1203 - 1207. [Abstract] [Full Text] [PDF]

				G. A. Ferreira, T. P. Navarro, R. W. Telles, L. E. C. Andrade, and E. I. Sato Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial Rheumatology, October 1, 2007; 46(10): 1560 - 1565. [Abstract] [Full Text] [PDF]

				O. Nived, M. Andersson, M. Lindgren, P. Malcus-Johnsson, A. Nihlberg, K. Nived, G. Reimer-Rasmusson, G. Sturfelt, C. Stahl-Hallengren, and A.A. Bengtsson Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire Lupus, September 1, 2007; 16(9): 701 - 706. [Abstract] [PDF]

				E Matsuura, K Kobayashi, B. Hurley, and L. Lopez Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome Lupus, July 1, 2006; 15(7): 478 - 483. [Abstract] [PDF]

				L R Lopez, M Salazar-Paramo, C Palafox-Sanchez, B L Hurley, E Matsuura, and I Garcia-De La Torre Oxidized low-density lipoprotein and {beta}2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis Lupus, February 1, 2006; 15(2): 80 - 86. [Abstract] [PDF]

				C. Gorman and D. Isenberg Atherosclerosis and lupus Rheumatology, August 1, 2004; 43(8): 943 - 945. [Full Text] [PDF]

				A Theodoridou, L Bento, D P D'Cruz, M A Khamashta, and G R V Hughes Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study Ann Rheum Dis, December 1, 2003; 62(12): 1199 - 1203. [Abstract] [Full Text] [PDF]

				E M C Sella, E I Sato, W A Leite, J A O. Filho, and A Barbieri Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus Ann Rheum Dis, November 1, 2003; 62(11): 1066 - 1070. [Abstract] [Full Text] [PDF]